Large-scale testing (Phase 3)Study completedNCT00319033What this trial is testingOpen-label Study With Bosentan in Interstitial Lung DiseaseWho this might be right forInterstitial Lung DiseaseScleroderma Actelion 132
Early research (Phase 1)Study completedNCT03675581What this trial is testingTest Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)Who this might be right forScleroderma, Systemic Boehringer Ingelheim 17
Testing effectiveness (Phase 2)Study completedNCT01988506What this trial is testingInduction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesWho this might be right forRheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more Assistance Publique - Hôpitaux de Paris 81
Not applicableUnknownNCT05445817What this trial is testingPulmonary Care and Research Collaborative Patient RegistryWho this might be right forInterstitial Lung Disease Pulmonary Care and Research Collaborative Limited 150
Not applicableStudy completedNCT03430388What this trial is testingYellow Fever Vaccine in Patients With Rheumatic DiseasesWho this might be right forSystemic LupusRheumatoid ArthritisSpondyloarthritis+8 more University of Sao Paulo General Hospital 600
Not applicableUnknownNCT03858842What this trial is testingNon-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017Who this might be right forLung Diseases, InterstitialLung Disease With Systemic Sclerosis Hospices Civils de Lyon 100
Large-scale testing (Phase 3)Study completedNCT00070590What this trial is testingEfficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With SclerodermaWho this might be right forPulmonary FibrosisScleroderma, Systemic Actelion 132
Not applicableLooking for participantsNCT01776398What this trial is testingCollection of Airway, Blood and/or Urine Specimens From Subjects for Research StudiesWho this might be right forChronic Obstructive Pulmonary Disease (COPD)SmokingSmoking Cessation+3 more Weill Medical College of Cornell University 2,000
Not applicableWithdrawnNCT05177471What this trial is testingEfficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung DiseaseWho this might be right forSystemic SclerosisInterstitial Lung Disease Central Hospital, Nancy, France
Testing effectiveness (Phase 2)Ended earlyNCT02745145What this trial is testingAbituzumab in SSc-ILDWho this might be right forSystemic Sclerosis-associated Interstitial Lung Disease EMD Serono Research & Development Institute, Inc. 24
Large-scale testing (Phase 3)Study completedNCT03313180What this trial is testingA Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung FibrosisWho this might be right forLung Diseases, Interstitial Boehringer Ingelheim 444
Not applicableActive Not RecruitingNCT04325217What this trial is testingPost-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in JapanWho this might be right forLung Diseases, Interstitial Boehringer Ingelheim 586
Large-scale testing (Phase 3)Looking for participantsNCT06716606What this trial is testingInvestigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)Who this might be right forConnective Tissue Diseases GlaxoSmithKline 514
Testing effectiveness (Phase 2)Looking for participantsNCT06350110What this trial is testingFourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus ErythematosusLupus NephritisAutoimmune Diseases+6 more Essen Biotech 75
Not applicableUnknownNCT05450276What this trial is testingPatient-Reported Outcome Study of Project ECHO for ILDWho this might be right forInterstitial Lung Disease Pulmonary Care and Research Collaborative Limited 56
Large-scale testing (Phase 3)WithdrawnNCT03726398What this trial is testingCompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PHWho this might be right forInterstitial Lung DiseaseSclerodermaPulmonary Hypertension Franz Rischard, DO
Testing effectiveness (Phase 2)Looking for participantsNCT06189495What this trial is testingA Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung DiseaseWho this might be right forSystemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) Changchun GeneScience Pharmaceutical Co., Ltd.
Not applicableLooking for participantsNCT06732674What this trial is testingHome Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic DiseasesWho this might be right forInterstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified ElsewhereSystemic Sclerosis PulmonaryDermatomyositis+3 more Oslo University Hospital 218
Post-approval studies (Phase 4)Looking for participantsNCT07087912What this trial is testingSafety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesWho this might be right forRheumatoid Arthritis (RA)Juvenile Idiopathic Arthritis (JIA)Systemic Lupus Erythematosus (SLE)+9 more University of Sao Paulo General Hospital 477
Not applicableEnrolling By InvitationNCT06472362What this trial is testingChest CT Biomarkers as Prognostic Predictors in SSc-ILDWho this might be right forSystemic Sclerosis Royal Brompton & Harefield NHS Foundation Trust 1,000